UCB Pharma AS is a pharmaceutical company with headquarters in Oslo. The company is part of the international UCB group, which specializes in the development of medicines for the treatment of serious diseases. UCB Pharma focuses particularly on areas such as neurology and immunology, and works with research and development of innovative treatments for patients.
The company is engaged in clinical studies and collaborates with the healthcare system to improve treatment options within its specialist fields. UCB Pharma AS aims to contribute to a better quality of life for patients through effective and safe medicines. The company's activities also include the production and distribution of pharmaceuticals, as well as collaboration with other players in the health industry to promote research and development.